Literature DB >> 6332367

[Anti-B-lymphocyte antibodies in rheumatoid polyarthritis. I.--1st findings in 22 patients].

P Mercier, R Montagnie, C Olmeta, J P Mattei, A Dutour, H Roux.   

Abstract

Anti B and T lymphocyte antibodies were sought in the serum of 22 rheumatoid arthritis patients from the Marseille area. No immunization against T lymphocytes was found. In contrast anti B lymphocyte activity was demonstrated in every diluted serum tested against a panel of 21 cells. In these sera, the complement dependent cytotoxicity was of medium intensity (lysis - 50 to 90 percent), antibody titers were high (medium 1/512) and a zone phenomenon was observed in 14 out of 22 non-diluted sera. As a rule, serum reactivity was slightly higher at 4 degrees C than at 22 degrees or 37 degrees C but at the latter temperature, it seemed to be more related to the target cells than to the serum tested. These anti B lymphocyte antibodies were predominantly IgMs and were not autoantibodies. Their specificity is still under study but already appears to be wide and not HLA related. These antibodies reacted with 9 to 100 percent of the panel cells and 85 percent of the sera recognized over 50 percent of the cells. Thus the antigenic determinants were probably allotypes or idiotypes of Fab fragments from surface immunoglobulins of a B lymphocyte subpopulation. Thus far, no relationship has been demonstrated between the presence or the titer of these antibodies and clinical, biological or genetic features of rheumatoid arthritis. In the future, this method should simplify the detection of Ig seric groups. It already allows detection of antiglobulin factors which could play an immunoregulatory role in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332367

Source DB:  PubMed          Journal:  Rev Rhum Mal Osteoartic        ISSN: 0035-2659


  1 in total

1.  IgM antiplatelet antibodies in 7 out of 20 rheumatoid arthritis sera. A new antiplatelet antibody ELISA. Reverse correlation with anti-B-lymphocyte antibodies in the same sera.

Authors:  P Mercier; C Dabanian; J Roudier; H Roux
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.